Reducing negative side effects from neural stimulation: Key Neurotech Patent #24

– Illustrative image from U.S. Patent No. 7,024,247 We are featuring today a 2006 patent, assigned to Advanced Neuromodulation Systems, especially relevant for brain stimulation methods which may carry some negative side effects. U.S. Patent No. 7,024,247: Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures. Assignee(s): Advanced Neuromodulation Systems, Inc. Inventor(s): Bradford Evan Gliner, Kent Leyde Technology Category: Transcranial Stimulation Issue Date: April 4, 2006 SharpBrains’ Take: Dealing with the problem of undesirable collateral activity during stimulation treatment, the ‘247 patent describes a “test” stimulation to determine thresholds for both patient responsivity (to the stimulation) and the parameters of a second treatment stimulation (to avoid collateral activity). Despite a short specification with four illustration sheets and six pages of written material, the ‘247 patent recites 55 claims with five independent claims covering various embodiments and versions of the inventive concept. The compelling claim set, along with the synergistic protection afforded when considered in tandem with the ‘305 patent (commonly assigned at the time of this writing) contribute to making the ‘247 patent a key non-invasive neurotechnology patent. Abstract: Test procedures for determining a neural stimulation threshold of a patient. In one embodiment, the procedure ...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Technology Advanced Neuromodulation Systems brain data brain-stimulation Inc neural stimulation neuro-technology patent transcranial stimulation Source Type: blogs